EpiPharma Therapeutics Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 1

EpiPharma Therapeutics General Information

Description

Developer of an investigational drug intended for the treatment of eosinophilic esophagitis.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Victoria, British Columbia
  • Canada
Primary Industry
Drug Discovery
Corporate Office
  • Victoria, British Columbia
  • Canada

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

EpiPharma Therapeutics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore EpiPharma Therapeutics‘s full profile, request access.

Request a free trial

EpiPharma Therapeutics FAQs

  • Where is EpiPharma Therapeutics headquartered?

    EpiPharma Therapeutics is headquartered in Victoria, Canada.

  • What industry is EpiPharma Therapeutics in?

    EpiPharma Therapeutics’s primary industry is Drug Discovery.

  • Is EpiPharma Therapeutics a private or public company?

    EpiPharma Therapeutics is a Private company.

  • What is EpiPharma Therapeutics’s current revenue?

    The current revenue for EpiPharma Therapeutics is .

  • When was EpiPharma Therapeutics acquired?

    EpiPharma Therapeutics was acquired on 01-Jan-2023.

  • Who acquired EpiPharma Therapeutics?

    EpiPharma Therapeutics was acquired by Eupraxia Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process